Biohaven files prospectus supplement for resale of 211,418 common shares by selling shareholders

Biohaven Ltd.

Prospectus supplement filed on May 17, 2024 for resale of 211,418 common shares issued as share consideration.
Shares were issued to selling shareholders in connection with prior transactions and business arrangements.
Legal opinion from Maples & Calder filed as Exhibit 5.1, incorporated into the S-3 registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.